Price Chart

Profile

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
URL https://www.novartis.com
Investor Relations URL https://www.novartis.com/investors
HQ State/Province N/A
Sector Healthcare
Industry Drug Manufacturers - General
Equity Style Large Cap/Blend
Next Earnings Release Apr. 23, 2024
Last Earnings Release Jan. 31, 2024
Next Ex-Dividend Date Mar. 07, 2024
Last Ex-Dividend Date Mar. 09, 2023

Profile

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
URL https://www.novartis.com
Investor Relations URL https://www.novartis.com/investors
HQ State/Province N/A
Sector Healthcare
Industry Drug Manufacturers - General
Equity Style Large Cap/Blend
Next Earnings Release Apr. 23, 2024
Last Earnings Release Jan. 31, 2024
Next Ex-Dividend Date Mar. 07, 2024
Last Ex-Dividend Date Mar. 09, 2023